Identifying Patients at Risk of Delayed Breast Imaging Due to the COVID-19 Pandemic.

breast cancer care breast imaging cancer screening covid-19 delayed care screening mammography

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
accepted: 16 08 2021
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 21 9 2021
Statut: epublish

Résumé

Epidemiological models predict worse cancer outcomes due to COVID-19 pandemic-related delays in cancer surveillance and treatment. This study evaluated patient demographic factors associated with delayed breast imaging or procedure appointments due to COVID-19. Patients attending a breast imaging or procedure appointment at the Pennsylvania Hospital Breast Center from December 28, 2020 to January 31, 2021 were asked to complete a voluntary and anonymous survey on the impact of COVID-19. Chi-squared and two-sample t-tests were used to analyze correlations between having a delayed appointment and various demographic variables. Five hundred seventy patients completed the survey. Participants were more likely to have delayed a breast imaging or procedure appointment if they were younger (53.9 versus 57.4 years old, p=0.014), had more total household residents (2.7 versus 2.2, p=0.019) or children (0.8 versus 0.4, p=0.016), personally had COVID-19 (p=0.04), or personally had to quarantine (p<0.01). Race, ethnicity, education, income level, and marital status were not found to statistically significantly correlate with having a delayed appointment. This study found that younger age, a greater number of residents and children in the household, and having a personal history of COVID-19 infection or quarantining were factors significantly correlated with delaying a breast imaging or procedure appointment. As radiology practices prepare to mitigate the impact of COVID-19 on screening practices and cancer outcomes, these findings may help imaging centers refine patient outreach efforts and policy accommodations to protect the most vulnerable populations.

Identifiants

pubmed: 34540462
doi: 10.7759/cureus.17235
pmc: PMC8443468
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e17235

Informations de copyright

Copyright © 2021, Li et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cancer. 2020 Oct 15;126(20):4466-4472
pubmed: 32749697
Science. 2020 Jun 19;368(6497):1290
pubmed: 32554570
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
In Vivo. 2020 Jun;34(3 Suppl):1651-1659
pubmed: 32503825
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
JAMA Netw Open. 2020 Aug 3;3(8):e2017267
pubmed: 32749465
Breast Cancer Res Treat. 2020 Jun;181(3):487-497
pubmed: 32333293
Breast Cancer Res Treat. 2020 Nov;184(1):249-254
pubmed: 32772225
Breast J. 2020 Nov;26(11):2316-2319
pubmed: 32881180
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
Radiol Clin North Am. 2021 Jan;59(1):1-11
pubmed: 33222992
Cancer. 2020 Dec 15;126(24):5202-5205
pubmed: 32914864
J Am Coll Radiol. 2020 Jul;17(7):865-872
pubmed: 32425710

Auteurs

Shiyi Li (S)

Interventional Radiology, Einstein Medical Center Philadelphia, Philadelphia, USA.

Sophia O'Brien (S)

Radiology, Hospital of University of Pennsylvania, Philadelphia, USA.

Christina Murphy (C)

Radiology, Perelman School of Medicine, Philadelphia, USA.

Calisi Nabil (C)

Radiology, Emory University School of Medicine, Atlanta, USA.

Classifications MeSH